STING Degrader-3
STING Degrader-3 is a PROTAC-like STING degrader with a DC50 of 2.58 μM in THP-1 cells. STING Degrader-3 degrades STING protein via the lysosomal pathway. STING Degrader-3 functions as a non-degradative inhibitor in macrophages. STING Degrader-3 reduces the phosphorylation levels of TBK1 and IRF3, and downregulates the expression of IFN-β, CXCL10, IL-6, TNFα, IL-1β, ISG15 and ISG56. STING Degrader-3 exhibits renoprotective properties in a cisplatin-induced acute kidney injury model. STING Degrader-3 can be used in studies related to acute kidney injury. ((Pink: STING ligand (HY-168676); Blue: CRBN ligand (HY-126457); Black: linker (HY-W123015); CRBN ligand + linker: (HY-168677)).
For research use only. We do not sell to patients.
- Formula: C35H33N7O11
- Molecular Weight:727.68
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
TBK1 |
IL-1β |
IL-6 |
In Vitro
STING Degrader-3 (Compound P8) (0.076-20 μM; 3-36 h) potently degrades STING protein in THP-1 cells, with a DC50 of 2.58 μM at 24 h, and exhibits time- and dose-dependent activity[1].
STING Degrader-3 (2.5-40 μM; 24 h) selectively degrades STING protein in THP-1 cells without affecting inflammation-related proteins STAT3 or AKT[1].
STING Degrader-3 (3-10 μM; 12-48 h) degrades STING protein in THP-1 cells via the lysosomal pathway (rather than the proteasomal pathway), without affecting STING mRNA levels, and STING protein expression recovers within 24 h after removal of the compound[1].
STING Degrader-3 (0.3-20 μM, 0-48 h) inhibits the activation of cGAMP (HY-12512)-induced STING downstream signaling pathway in THP-1 cells, reduces the phosphorylation levels of TBK1 and IRF3, and downregulates the mRNA levels of pro-inflammatory cytokines and interferon-stimulated genes[1].
STING Degrader-3 (0.3-30 μM; 24 h, 1 h pretreatment + 24 h stimulation) acts as a STING pathway inhibitor (rather than a degrader) in RAW264.7 cells. It reduces DMXAA (HY-10964)-induced downstream signal transduction and mRNA levels of proinflammatory mediators without altering STING protein levels[1].
STING Degrader-3 (0.33-90 μM; 48 h) exhibits low cytotoxicity in normal human HEK293T and HUVEC cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:THP-1 cells
-
Concentration:0.076, 0.15, 0.3, 0.625, 1.25, 2.5, 10, 20 μM
-
Incubation Time:3, 6, 9, 12, 24, 36 h
-
Result:Achieved 82% degradation of STING protein at 10 μM for 24 h.
Exhibited dose-dependent degradation with a DC50 of 2.58 μM after 24 h treatment.
Started degrading STING protein at 9 h and reached maximum degradation levels at 24 h.
-
Cell Line:THP-1 cells
-
Concentration:0.3, 1.2, 5, 20 μM
-
Incubation Time:24 h pretreatment + 24 h cGAMP stimulation
-
Result:Suppressed cGAMP-induced pTBK1 and pIRF3 expression in a concentration-dependent manner.
Dose-dependently reduced cGAMP-induced mRNA levels of IFN-β, IL-6, CXCL10, TNFα, ISG15, and ISG56.
-
Cell Line:RAW264.7 cells
-
Concentration:0.33, 1.1, 3.3, 10, 30 μM (STING protein analysis); 0.3, 1.2, 5, 20 μM (signaling assay)
-
Incubation Time:24 h (STING protein analysis); 1 h pretreatment + 24 h DMXAA stimulation (signaling assay)
-
Result:Did not induce STING protein degradation at concentrations up to 30 μM after 24 h treatment.
Suppressed DMXAA-induced pTBK1 and pIRF3 expression in a concentration-dependent manner.
Dose-dependently reduced DMXAA-induced mRNA levels of IFN-β, IL-6, CXCL10, and TNFα.
-
Cell Line:human monocytic leukemia THP-1 cells
-
Concentration:2.5, 5, 10, 20, 40 μM
-
Incubation Time:24 h
-
Result:Degraded STING protein in a concentration-dependent manner.
Did not reduce protein levels of STAT3 or AKT at any tested concentration.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Eight-week-old C57BL/6J male mice[1]
-
Dosage:25, 50 mg/kg
-
Administration:i.p., 1 h prior to Cisplatin injection
-
Result:Alleviated Cisplatin-induced acute kidney injury in C57BL/6J mice, achieving a 100% survival rate.
Reduced levels of blood urea nitrogen, creatinine, and uric acid.
Downregulated the expression of IFN-β, CXCL10, IL-6, TNFα, IL-1β, ISG15, and ISG56.
Chemical Information
-
Molecular Weight 727.68
-
Formula C35H33N7O11
-
SMILES
O=C1CCC(C(N1)=O)N2C(C3=CC=CC(OCC4=CN(N=N4)CCCCCC(OCCC5=CC=C(C=C5)NC(C6=CC=C(O6)[N+]([O-])=O)=O)=O)=C3C2=O)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Nephrotoxicity Study
This protocol assesses nephrotoxicity by combining functional kidney injury readouts, urinary/tissue injury biomarkers, and renal histopathology. Serum creatinine and BUN reflect impaired kidney function, while KIM-1, NGAL, clusterin, osteopontin, IL-18, cystatin C, nephrin, Oat5, urinary protein, glucose, and alkaline phosphatase have been used to detect tubular injury in cisplatin-, gentamicin-, and acetaminophen-induced nephrotoxicity models.
-
Lysosome and acidic-vesicle live-cell staining
Lysosome and acidic-vesicle live-cell staining detects acidic intracellular compartments by using membrane-permeant acidotropic probes that accumulate in low-pH vesicles, including lysosomes, late endosomes, autolysosomes, and acidic phagosomes. LysoTracker staining is commonly used as an intensity-based readout of acidic lysosomal compartment abundance or enlargement, while acridine orange produces green fluorescence in less concentrated compartments and red fluorescence after concentration-dependent accumulation in acidic vesicular organelles. Loss or reduction of acridine-orange red signal can be used as a readout of lysosomal membrane permeabilization or reduced acidic-vesicle integrity. This protocol is designed for live cultured cells and can be adapted for fluorescence microscopy, high-content imaging, plate-reader readout, or flow cytometry when the selected literature supports the readout. Because these dyes report acidotropic accumulation rather than lysosome identity alone,
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
-
Pyroptosis Solutions
Pyroptosis is a lytic inflammatory cell-death pathway executed by gasdermin pores, most classically through inflammasome-mediated activation of caspase-1, cleavage of gasdermin D, membrane pore formation, LDH release, and secretion of IL-1β and IL-18. The canonical pathway is commonly modeled by priming cells with an inflammatory signal such as LPS to induce pro-IL-1β and inflammasome components, followed by an activation signal such as ATP or nigericin to activate NLRP3, ASC speck formation, caspase-1 cleavage, GSDMD cleavage, cytokine release, and pyroptotic membrane rupture. The non-canonical pathway is triggered when cytosolic LPS activates mouse caspase-11 or human caspase-4/5, leading to GSDMD cleavage and pyroptosis, and this can secondarily activate NLRP3-dependent IL-1β release. Pyroptosis is linked to inflammatory injury, infection, cancer, liver disease, ocular disease, placental inflammation, and other disease phenotypes, but unresolved questions include which gasdermin fam
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)